The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical utility of plasma cell-free DNA (cfDNA) in NET-02: Randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC).
 
Mairead Geraldine McNamara
Honoraria - Advanced Accelerator Applications (Inst); Novartis
Consulting or Advisory Role - AstraZeneca (Inst); Incyte; Ipsen; Shire; Sirtex Medical
Speakers' Bureau - AstraZeneca; Nucana
Research Funding - AstraZeneca (Inst); Ipsen (Inst); Nucana (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; Bayer; Novartis
 
Simon Pearce
No Relationships to Disclose
 
Jayne Swain
No Relationships to Disclose
 
Mollie Anne Halford
No Relationships to Disclose
 
Rohini Sharma
No Relationships to Disclose
 
Olusola Olusesan Faluyi
No Relationships to Disclose
 
Jonathan Wadsley
No Relationships to Disclose
 
Carys Morgan
No Relationships to Disclose
 
Lucy R. Wall
No Relationships to Disclose
 
Ian Chau
Honoraria - Bristol-Myers Squibb; Eisai; Lilly; Novartis; Roche/Genentech; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BioNTech SE; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; Lilly; Merck Serono; MSD Oncology; OncXerna Therapeutics; Roche/Genentech; Seagen; SERVIER; Sotio; Taiho Oncology; Turning Point Therapeutics
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - BMS; SERVIER
 
Nick Reed
Honoraria - Ipsen; Lilly; Novartis
Consulting or Advisory Role - Esteve; Esteve; Ipsen; Merck; Novartis; SeaGen
Research Funding - Exelixis (Inst); Ipsen (Inst); Lilly (Inst); Novartis (Inst)
 
Debashis Sarker
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - AAA HealthCare; Abbvie; AstraZeneca; Bayer; Eisai; Incyte; Ipsen; MSD Oncology; Novartis; Roche; Sirtex Medical; UCB (Inst)
Speakers' Bureau - AstraZeneca; Bayer; Eisai; Incyte; SERVIER
Research Funding - Inspirata (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Ipsen
(OPTIONAL) Uncompensated Relationships - Medivir; MINA THERAPEUTICS
 
Jane Margetts
No Relationships to Disclose
 
Alan Anthoney
No Relationships to Disclose
 
Jamie B. Oughton
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); SERVIER (Inst)
 
Angela Lamarca
Consulting or Advisory Role - Albireo Pharma; AstraZeneca/MedImmune; Boehringer Ingelheim; Boston Scientific; EISAI; GENFIT; Ipsen; MSD Oncology; Nutricia; QED Therapeutics; Roche; SERVIER; Taiho Pharmaceutical; TransThera Biosciences
Speakers' Bureau - Advanced Accelerator Applications; Advanz Pharma; AstraZeneca/MedImmune; Eisai; Incyte; Ipsen; Merck; MSD Oncology; Novartis; Pfizer; QED Therapeutics; Roche; SERVIER
Research Funding - Albireo Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); GENFIT (Inst); Ipsen; Merck (Inst); QED Therapeutics (Inst); Relay Therapeutics (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Advanz Pharma; Bayer; Celgene; Delcath Systems; Ipsen; Mylan; Novartis; Pfizer; Roche; Sirtex Medical
 
Richard Hubner
Consulting or Advisory Role - AstraZeneca; MSD; Novartis/Pfizer
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Roche
 
Dominic G. Rothwell
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Juan W. Valle
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Autem Medical; Baxter; Boehringer Ingelheim; Cantargia AB; Debiopharm Group; Delcath Systems; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Medivir; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Sirtex Medical; Taiho Oncology; Wren Laboratories; Zymeworks
Speakers' Bureau - Delcath Systems; Imaging Equipment Limited; Incyte; Ipsen; Mylan; Novartis; Nucana; SERVIER
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Lilly; Nucana; Roche
 
Alexandra Clipson
No Relationships to Disclose